3D printed medical devices are best in class therapeutic devices that include a procedure of creating three-dimensional solid objects from an advanced model. Understanding particular patient treatment is the principle preferred standpoint of 3D printing technology in the healthcare industry. In the area of healthcare, 3D printing technology is utilized to create therapeutic devices, for example, dental inserts, orthopedic inserts, prosthetics along with hearing aids.
The worldwide market for 3D printed medical devices is expected to expand at a double-digit CAGR of 17.7% over the conjecture phase and is anticipated to reach a value of US$ 1469.4 Million through 2026.
The overall market based on the materials includes metals and alloys, biomaterial inks (hydrogels, ceramics and polymers) and plastics (photopolymers and thermoplastics). The plastics material category dominated the worldwide market during 2015 in revenue share terms and is likely to continue all through the projected period. The plastics category accounted for 72.0% of the overall market share during 2016. The biomaterial Inks category will be recording the maximum double digit CAGR of 20.1 % over 2016-2026.
The overall market on the basis of the application is categorized into internal and external prostheses, cranio-maxillofacial implants, dental implants and orthopedic implants. The orthopedic implants dominated the worldwide market in revenue terms during 2015 and are likely to dominate during the estimated period, recording a higher CAGR. The category accounted for 19.9% of the overall market share during 2016.
Based on the technology, the overall market is segmented into selective laser sintering (SLS)–powder-based 3D printing, stereolithography (SLA)– liquid, digital light processing(DLP) based 3D printing, electronic beam melting (EBM), fused deposition modeling (FDM): plastic filament extrusion-based technology and polyjet / inkjet 3D printing. The SLS technology dominated the worldwide market during 2015 while the polyJet / inkJet 3D printing will be dominating all through the conjecture period, exhibiting a strong CAGR.
On the basis of the distribution channel, the overall market is divided into ambulatory surgical centers (ASCs), diagnostic centers and hospitals. The hospital division will be accounting for the largest market share, likely to account for about US$ 862.1 Million through 2026.
The overall market on the basis of the region is analyzed across Japan, Asia Pacific excluding Japan, Eastern Europe, Western Europe, Latin America, North America and Middle East and Africa. North America dominated the regional market through 2016 and will be registering a robust 19.2% CAGR during the conjecture period, followed by Western Europe registering an 18.5% CAGR during the calculated period further followed by APEJ, Eastern Europe and Japan.
Key Market Players
Some of the prominent players operating in the worldwide market for 3D printed medical devices are: Ar am AB, 3D Systems Inc., FabRx Ltd., Stratasys Ltd., EnvisionTEC, EOS GmbH Electro Optical Systems, Bio3D Technologies, Cyfuse Biomedical K.K.
Queries regarding these research findings can be addressed to Future Market Insights’ analysts at firstname.lastname@example.org